(Reuters) – Pfizer Inc’s COVID-19 vaccine could get British regulatory approval by the end of the week, The Telegraph reported on Sunday.
British regulators are about to start a formal appraisal of the vaccine by Pfizer and BioNTech SE, with the National Health Service told to be ready to administer the doses by Dec. 1, the Telegraph said https://bit.ly/3pPb5oF.
(Reporting by Ann Maria Shibu in Bengaluru; Editing by Lisa Shumaker)
